SAGE Insider Trading
SAGE | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at SAGE provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2023-08-11 15:51 | 2023-08-09 | Barrett Elizabeth | Director | BUY | $18.64 | 2,000 | $37,279 | 3,000 | +200.0% |
| 2023-05-11 15:58 | 2023-05-09 | Barrett Elizabeth | Director | BUY | $50.50 | 1,000 | $50,500 | 1,000 | +100.0% |
| 2023-02-11 00:42 | 2023-02-10 | JONAS JEFFREY M | Director | OPT+S | $44.61 | 11,643 | $519,413 | 121,981 | 0.0% |
| 2022-11-16 00:04 | 2022-11-10 | Greene Barry E | Director, Officer - President and CEO | BUY | $34.48 | 14,500 | $500,022 | 46,940 | +44.7% |
| 2022-05-09 16:32 | 2022-05-05 | Golumbeski George | Director | BUY | $31.45 | 8,000 | $251,563 | 8,000 | +100.0% |
| 2021-08-09 16:07 | 2021-08-05 | Greene Barry E | Director, Officer - President and CEO | BUY | $43.15 | 23,640 | $1,020,054 | 32,440 | +268.6% |
| 2021-06-17 23:04 | 2021-06-16 | FRATES JAMES M | Director | BUY | $55.10 | 1,810 | $99,735 | 1,810 | +100.0% |
| 2021-06-17 16:15 | 2021-06-16 | STARR KEVIN P | Director | BUY | $56.05 | 17,842 | $999,983 | 320,659 | +5.9% |
| 2021-06-17 16:14 | 2021-06-16 | Greene Barry E | Director, Officer - President and CEO | BUY | $56.32 | 8,800 | $495,627 | 8,800 | +100.0% |
| 2019-12-11 04:04 | 2019-12-09 | Robichaud Albert | Officer - Chief Scientific Officer | BUY | $64.16 | 25,000 | $1,604,000 | 136,400 | +22.4% |
| 2019-12-11 04:04 | 2019-12-09 | JONAS JEFFREY M | Director, Officer - President & CEO | BUY | $64.20 | 7,500 | $481,500 | 54,530 | +15.9% |
| 2019-08-16 23:04 | 2019-08-15 | FRATES JAMES M | Director | OPT+S | $160.58 | 8,000 | $1,284,640 | 2,535 | 0.0% |
| 2019-05-29 23:01 | 2019-05-28 | JONAS JEFFREY M | Director, Officer - President & CEO | OPT+S | $174.78 | 85,736 | $14,984,587 | 12,115 | 0.0% |
| 2019-05-25 01:24 | 2019-05-23 | JONAS JEFFREY M | Director, Officer - President & CEO | OPT+S | $174.75 | 94,264 | $16,472,794 | 62,115 | 0.0% |
| 2019-05-24 23:00 | 2019-05-22 | Cloonan Michael | Officer - Chief Business Officer | OPT+S | $175.00 | 25,000 | $4,375,000 | 461 | 0.0% |
| 2019-05-10 23:31 | 2019-05-10 | Cook Anne Marie | Officer - SVP, GC & Secretary | OPT+S | $166.14 | 15,000 | $2,492,100 | 0 | 0.0% |
| 2019-05-07 01:21 | 2019-05-06 | FRATES JAMES M | Director | OPT+S | $162.22 | 8,000 | $1,297,760 | 4,235 | 0.0% |
| 2019-03-22 23:22 | 2019-03-21 | PAUL STEVEN M | Director | SELL | $161.04 | 7,879 | $1,268,824 | 122,400 | -6.0% |
| 2019-03-21 03:47 | 2019-03-18 | PAUL STEVEN M | Director | SELL | $161.28 | 60,421 | $9,744,560 | 130,279 | -31.7% |
| 2019-03-06 00:18 | 2019-03-01 | PAUL STEVEN M | Director | SELL | $161.00 | 2,600 | $418,600 | 190,700 | -1.3% |
| 2019-03-02 00:46 | 2019-03-01 | IGUCHI KIMI | Officer - CFO & Treasurer | SELL | $156.93 | 25,563 | $4,011,602 | 1,413 | -94.8% |
| 2019-02-28 01:48 | 2019-02-25 | PAUL STEVEN M | Director | SELL | $161.00 | 2,000 | $322,000 | 70,900 | -2.7% |
| 2019-02-20 15:55 | 2019-02-15 | PAUL STEVEN M | Director | SELL | $161.04 | 51,004 | $8,213,582 | 72,900 | -41.2% |
| 2019-02-15 01:45 | 2019-02-12 | STARR KEVIN P | Director | SELL | $0.00 | 0 | $0 | 0 | -100.0% |
| 2019-02-09 01:08 | 2019-02-08 | Kanes Stephen | Officer - Chief Medical Officer | SELL | $150.00 | 22,948 | $3,442,200 | 941 | -96.1% |
| 2019-01-25 01:44 | 2019-01-23 | FRATES JAMES M | Director | OPT+S | $134.81 | 7,500 | $1,011,075 | 4,235 | 0.0% |
| 2018-05-08 23:51 | 2018-05-08 | FRATES JAMES M | Director | OPT+S | $154.00 | 7,000 | $1,078,000 | 5,000 | 0.0% |
| 2018-04-27 23:23 | 2018-04-26 | IGUCHI KIMI | Officer - CFO & Treasurer | SELL | $144.20 | 12,782 | $1,843,214 | 25,563 | -33.3% |
| 2018-04-26 00:44 | 2018-04-23 | IGUCHI KIMI | Officer - CFO & Treasurer | SELL | $142.73 | 28,153 | $4,018,297 | 38,345 | -42.3% |
| 2018-04-19 23:35 | 2018-04-17 | STARR KEVIN P | Director | SELL | $168.85 | 59,000 | $9,962,250 | 302,817 | -16.3% |
| 2018-03-09 00:02 | 2018-03-06 | PAUL STEVEN M | Director | SELL | $172.00 | 58,139 | $9,999,908 | 632,712 | -8.4% |
| 2018-01-13 00:07 | 2018-01-10 | Kanes Stephen | Officer - Chief Medical Officer | OPT+S | $177.18 | 44,000 | $7,795,836 | 2,948 | 0.0% |
| 2017-12-23 00:02 | 2017-12-21 | JONAS JEFFREY M | Director, Officer - President & CEO | OPT+S | $157.31 | 223,000 | $35,079,372 | 1,226 | 0.0% |
| 2017-12-15 02:51 | 2017-12-14 | Robichaud Albert | Officer - Chief Scientific Officer | SELL | $159.43 | 60,000 | $9,565,956 | 94,259 | -38.9% |
| 2017-01-13 23:51 | 2017-01-13 | IGUCHI KIMI | Officer - CFO, Secretary and Treasurer | SELL | $53.92 | 10,000 | $539,200 | 66,498 | -13.1% |
| 2016-11-29 00:03 | 2016-11-15 | Anderson Thomas | Officer - See Remarks | OPT+S | $55.00 | 10,000 | $550,000 | 0 | 0.0% |
| 2016-11-19 00:01 | 2016-11-17 | IGUCHI KIMI | Officer - CFO, Secretary and Treasurer | SELL | $51.77 | 4,000 | $207,080 | 75,739 | -5.0% |
| 2016-11-14 20:55 | 2016-11-11 | IGUCHI KIMI | Officer - CFO, Secretary and Treasurer | SELL | $50.59 | 1,500 | $75,885 | 79,739 | -1.8% |
| 2016-09-09 17:25 | 2016-09-07 | IGUCHI KIMI | Officer - CFO, Secretary and Treasurer | SELL | $40.93 | 2,500 | $102,325 | 81,239 | -3.0% |
| 2016-07-14 23:11 | 2016-07-12 | Robichaud Albert | Officer - Chief Scientific Officer | SELL | $40.00 | 22,000 | $880,000 | 140,222 | -13.6% |
| 2016-07-14 23:10 | 2016-07-12 | IGUCHI KIMI | Officer - CFO, Secretary and Treasurer | SELL | $49.55 | 5,000 | $247,750 | 83,739 | -5.6% |
| 2016-05-18 23:27 | 2016-05-16 | Third Rock Ventures II, L.P. | 10% owner | SELL | $31.25 | 850,000 | $26,562,500 | 3,892,916 | -17.9% |
| 2016-05-18 23:24 | 2016-05-16 | STARR KEVIN P | Director, 10% owner | SELL | $31.25 | 850,000 | $26,562,500 | 3,892,916 | -17.9% |
| 2016-04-21 20:53 | 2016-04-19 | Kanes Stephen | Officer - Chief Medical Officer | OPT+S | $38.00 | 21,000 | $798,000 | 25,948 | 0.0% |
| 2016-01-26 22:18 | 2016-01-25 | Robichaud Albert | Officer - Chief Scientific Officer | SELL | $40.02 | 20,000 | $800,400 | 162,222 | -11.0% |
| 2016-01-08 00:54 | 2015-12-31 | IGUCHI KIMI | Officer - CFO, Secretary and Treasurer | BUY | $49.56 | 176 | $8,723 | 84,739 | +0.2% |
| 2016-01-08 00:54 | 2015-12-31 | JONAS JEFFREY M | Director, Officer - See Remarks | BUY | $49.56 | 226 | $11,201 | 81,226 | +0.3% |
| 2015-09-30 01:24 | 2015-09-28 | Kanes Stephen | Officer - Chief Medical Officer | OPT+S | $46.42 | 6,000 | $278,520 | 46,948 | 0.0% |
| 2015-09-09 19:08 | 2015-09-08 | IGUCHI KIMI | Officer - CFO, Secretary and Treasurer | SELL | $54.84 | 3,000 | $164,520 | 84,563 | -3.4% |
| 2015-09-02 22:43 | 2015-09-01 | PAUL STEVEN M | Director | SELL | $52.41 | 20,000 | $1,048,184 | 683,650 | -2.8% |
How to Interpret $SAGE Trades
Not every insider transaction in SAGE is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $SAGE shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for SAGE
Insider activity data for SAGE is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $SAGE, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.